USE OF A SYNERGISTIC COMBINATION OF CHLOROGENIC ACID AND 3-O-P-COUMARYL QUINIC ACID AS AN ANTI-LEUKEMIC THERAPY

摘要

The present invention relates to a new use of the compound chlorogenic acidisolated from the piper betel leaf extract or from any other sources for thetreatment of acute and chronic myeloid leukemia and lymphoid leukemia, and thepresent invention also provides a pharmaceutical composition comprisingchloregenic acid along with pharmaceutically acceptable additive for thetreatment of acute and chronic myeloid leukemia and lymphoid leukemia.